CS Gautam1, Roosy Aulakh2* and Priyanka Bhateja3
1Professor and Head, Department of Pharmacology, Government Medical College and Hospital, Chandigarh, India
1Professor, Department of Pediatrics, Government Medical College and Hospital, Chandigarh, India
*Corresponding Author: Roosy Aulakh, Professor, Department of Pediatrics, Government Medical College and Hospital, Chandigarh, India.
Received: March 20, 2020; Published: March 23, 2020
The world today has a new challenge, the novel coronavirus (2019-nCoV) pandemic which emerged in China in early December 2019 and has brought the entire world to standstill with over 2 lac cases and nearly 9000 deaths reported worldwide. As the virus has been demonstrated to have high transmissibility with humans worldwide lacking immunity, an exponential rise in cases is expected in countries where initial cases have just emerged. Though researchers have documented efficacy of anti-viral drugs like Remdesivir/Lopinavir/Ritonavir/Ribavarin in treating cases of pneumonia caused by COVID-19 , these drugs are neither easily available nor is it financially feasible to use these drugs in developing countries like India.
Keywords: Novel Coronavirus (2019-nCoV); Pandemic; Anti-Viral Drugs; Armamentarium
Citation: CS Gautam and Roosy Aulakh. “Potential Armamentarium to Contain COVID-19 Pandemic in Developing Countries: Be Prepared and Act Timely!" Acta Scientific Paediatrics 3.4 (2020): 39-42.
Copyright: © 2020 CS Gautam and Roosy Aulakh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.